PIAS1,2-1 SUMOylate NR5A2 with SUMO1

Stable Identifier
R-HSA-4755494
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

PIAS1,2-1 SUMOylate NR5A2 (LRH-1) with SUMO1 at lysine-270 (lysine-224 in the shorter isoform) (Chalkiadaki and Talianidis 2005, Ogawa et al. 2009, Venteclef et al. 2010). SUMOylation is enhanced when NR5A2 is bound to ligand. SUMOylated NR5A2 acts as a transrepressor of genes involved in inflammation such as haptoglobin, SAA, and CRP.

Literature References
PubMed ID Title Journal Year
20159957 GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response

Venteclef, N, Jakobsson, T, Ehrlund, A, Damdimopoulos, A, Mikkonen, L, Ellis, E, Nilsson, LM, Parini, P, Jänne, OA, Gustafsson, JA, Steffensen, KR, Treuter, E

Genes Dev. 2010
19692572 Transcriptional Suppression by Transient Recruitment of ARIP4 to Sumoylated nuclear receptor Ad4BP/SF-1

Ogawa, H, Komatsu, T, Hiraoka, Y, Morohashi, K

Mol. Biol. Cell 2009
15923626 SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin

Chalkiadaki, A, Talianidis, I

Mol. Cell. Biol. 2005
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
SUMO transferase activity of PIAS1,2-1 [nucleoplasm]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created